查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1808403

動物感染疾病診斷市場（依疾病類別、產品、動物類型和最終用途）－2025-2030 年全球預測

Veterinary Infectious Disease Diagnostics Market by Disease Category, Product, Offering, Animal Type, End Use - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計動物感染疾病診斷市場規模到 2024 年將達到 22.4 億美元，到 2025 年將達到 24.2 億美元，到 2030 年將達到 36.3 億美元，複合年成長率為 8.37%。

主要市場統計數據
基準年2024年 22.4億美元
預計2025年 24.2億美元
預計2030年 36.3億美元
複合年成長率（%） 8.37%

為獸醫感染疾病診斷的突破性進展及其對動物健康管理的影響奠定基礎

獸醫感染疾病診斷技術的進步正在重塑臨床醫生和研究人員的動物健康管理方式。尖端分子技術、快速就地檢驗和數據驅動的決策支援工具的融合，使得伴侶動物和生產動物的致病威脅能夠更早發現並更準確地識別。因此，獸醫專業人員現在能夠主動干預，降低發病率和死亡率，同時最大限度地降低通用感染疾病的傳播風險。

揭開重新定義獸醫感染疾病診斷領域並推動整個動物健康領域臨床創新的革命性變化

在獸醫診斷領域，幾個關鍵趨勢正在匯聚，重新定義感染疾病檢測和監測的範式。其中最主要的是從單一分析物檢測到多重和綜合組合檢測的轉變。透過同時檢測多種病原體，這些進步縮短了診斷時間，並提供更全面的臨床資訊。分析硬體的微型化進一步放大了這項變革，支援在現場環境和遠端診所部署攜帶式設備。

2025年美國新關稅對動物感染疾病診斷供應供應鏈和創新影響的全面評估

美國將於2025年對進口獸醫診斷產品加徵關稅，將為全球供應鏈帶來新的複雜性。試劑、檢測套組和分析儀組件的供應商正面臨成本上漲，這些成本已開始滲透到定價結構中。這些成本的增加迫使製造商和最終用戶重新評估籌資策略和庫存管理通訊協定。

揭示全面的細分洞察，重點介紹各種動物感染疾病診斷類別和產品的關鍵促進因素和成長模式

可以從幾個關鍵角度審視動物感染疾病診斷市場，以揭示獨特的促進因素和新的商機。鑑於病原體的多樣性，鉤端螺旋體病和布氏桿菌症等細菌感染疾病需要快速的確認檢測，而細小病毒和犬瘟熱等病毒感染疾病則受益於高通量分子檢測。細小病毒和犬瘟熱等病毒威脅受益於高通量分子檢測。真菌病原體雖然不太常見，但需要專門的培養和血清學檢測平台，而寄生蟲感染則需要高靈敏度的免疫檢測來檢測循環抗原。

分析影響全球主要市場中成熟經濟體和新興經濟體動物感染疾病診斷未來的地理模式和區域動態

獸醫感染疾病診斷的區域動態受動物所有權模式、農業實踐和法律規範差異的影響。在美洲，美國和加拿大憑藉其強大的研究基礎設施和成熟的獸醫網路，在技術應用方面處於領先地位。隨著畜牧業產量的擴大和伴侶動物照護的日益複雜化，拉丁美洲市場正在迅速發展，推動了對經濟高效的診斷解決方案的需求。

介紹推動動物感染疾病診斷突破和增強市場競爭力的關鍵創新者和策略夥伴關係

少數幾家主要企業正推動動物感染疾病診斷領域的創新，這些公司將卓越的研究成果與策略聯盟結合。市場領導者致力於開發全面的分子診斷平台，以實現具有高分析靈敏度的多重病原體檢測。這些平台與專為現場應用設計的試劑組相輔相成，使實驗室診斷能力能夠無縫遷移到農場和診所環境。

實施以相關人員為目標的策略和營運框架，以加速獸醫診斷領域的發展並克服挑戰

尋求抓住新商機的產業領導者應優先投資能夠實現多重病原體檢測的下一代分子平台。擴大內部研發能力或與專業生技公司合作，可加速產品上市時間，並確保產品符合臨床需求。此外，透過多元化籌資策略和在地化生產增強供應鏈韌性，可以降低關稅和物流風險。

嚴謹的調查方法結合定量分析和專家檢驗，為獸醫感染疾病診斷提供了可靠的見解

本報告的研究結果基於嚴謹的調查方法，融合了定量分析和專家檢驗。市場洞察基於二手資料研究，利用同行評審期刊、公共衛生資料庫、監管文件和技術白皮書。全面的文獻綜述提供了對新興趨勢和技術突破的透徹理解。

摘要關鍵見解和策略重點，為不斷發展的動物感染疾病診斷生態系統的決策提供參考

摘要：由於技術創新、法規演變和貿易政策變化，動物感染疾病診斷市場正經歷重大變革時期。多重分子檢測、照護現場設備和數據分析平台的興起正在重新定義診斷工作流程，並使伴侶動物和牲畜的疾病管理更加積極主動。

目錄

第1章：前言

第2章調查方法

第3章執行摘要

第4章 市場概況

第5章市場動態

  • 開發用於同時檢測伴侶動物中通用感染疾病的多重PCR檢測板
  • 擴大基於 CRISPR 的診斷方法，實現快速、現場可部署的獸醫病原體鑑定
  • 整合人工智慧影像分析工具，在牲畜健康檢查中及早發現感染疾病標記物
  • 用於現場篩檢牲畜抗生素抗藥性的可攜式微流體生物感測器裝置的開發
  • 利用次世代定序全面監測新興病毒和細菌病原體
  • 實施具有遠距離診斷測試的遠端醫療平台，以改善農村地區獲得獸醫護理的機會
  • 獸醫診斷測試的標準化和監管協調，以簡化全球市場核准
  • 側流免疫檢測技術在禽類養殖中用於經濟有效的地方病常規監測的進展
  • 利用數位資料分析平台將診斷結果與農場管理系統結合，以獲得即時洞察
  • 寵物醫療成本的上漲和健康趨勢的上升正在推動伴侶動物感染疾病診斷的擴大

第6章 市場洞察

  • 波特五力分析
  • PESTEL分析

第7章 2025年美國關稅的累積影響

第 8 章：動物感染疾病診斷市場（依疾病類別）

  • 細菌
  • 真菌
  • 寄生蟲
  • 病毒性的

第9章動物感染疾病診斷市場（依產品）

  • 耗材
    • 試劑
    • 檢測套組
  • 儀器/分析儀
    • 臨床化學分析儀
    • 血液分析儀
    • 免疫診斷分析儀
    • 分子診斷分析儀

第 10 章動物感染疾病診斷市場（依產品提供）

  • 硬體
  • 服務
  • 軟體

第11章動物感染疾病診斷市場（依動物類型）

  • 伴侶動物
    • 貓
    • 狗
  • 牲畜/生產動物
    • 牛
    • 山羊
    • 家禽
    • 羊
    • 豬

第 12 章：動物感染疾病診斷市場（依最終用途）

  • 內部測試設施
    • 動物收容所
    • 寵物飼主
  • 實驗室
  • 獸醫醫院和診所

13.美洲動物感染疾病診斷市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 阿根廷

14.歐洲、中東和非洲動物感染疾病診斷市場

  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 阿拉伯聯合大公國
  • 沙烏地阿拉伯
  • 南非
  • 丹麥
  • 荷蘭
  • 卡達
  • 芬蘭
  • 瑞典
  • 奈及利亞
  • 埃及
  • 土耳其
  • 以色列
  • 挪威
  • 波蘭
  • 瑞士

15. 亞太動物感染疾病診斷市場

  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國
  • 印尼
  • 泰國
  • 菲律賓
  • 馬來西亞
  • 新加坡
  • 越南
  • 台灣

第16章競爭格局

  • 2024年市場佔有率分析
  • 2024年FPNV定位矩陣
  • 競爭分析
    • IDEXX Laboratories, Inc.
    • Zoetis Inc.
    • Agrolabo SpA
    • Antech Diagnostics, Inc.
    • Bio-Rad Laboratories, Inc.
    • Biogal Galed Labs
    • BioMerieux SA
    • BioNote, Inc.
    • Demeditec Diagnostics GmbH
    • DEXX Laboratories Inc.
    • Eurofins Technologies
    • Fassisi GmbH
    • FUJIFILM Holdings Corporation
    • IDvet
    • Mars, Incorporated
    • Merck & Co., Inc.
    • Neogen Corporation
    • Nisseiken Co., Ltd
    • Qiagen NV
    • Randox Laboratories, Ltd.
    • Shenzhen Bioeasy Biotechnology Co., Ltd.
    • Shenzhen Mindray Animal Medical Technology Co., Ltd.
    • SKYER, Inc.
    • Skyla Corporation
    • Thermo Fisher Scientific Inc.
    • Vimian Group AB
    • Virbac SA

第17章 研究人工智慧

第18章 研究統計

第19章 研究聯絡人

第20章 研究報導

第21章 附錄

Product Code: MRR-742BD5184F0A

The Veterinary Infectious Disease Diagnostics Market was valued at USD 2.24 billion in 2024 and is projected to grow to USD 2.42 billion in 2025, with a CAGR of 8.37%, reaching USD 3.63 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 2.24 billion
Estimated Year [2025] USD 2.42 billion
Forecast Year [2030] USD 3.63 billion
CAGR (%) 8.37%

Setting the Stage for Transformative Advances in Veterinary Infectious Disease Diagnostics and Their Impact on Animal Health Management

Advances in veterinary infectious disease diagnostics are reshaping the way clinicians and researchers approach animal health management. The convergence of cutting-edge molecular techniques, rapid point-of-care testing, and data-driven decision support tools enables earlier detection and more accurate identification of pathogenic threats across both companion and production species. Consequently, veterinary professionals are now equipped with the capacity to intervene proactively, reducing morbidity and mortality while also minimizing the risk of zoonotic transmission.

Over the past decade, growing awareness of One Health principles has intensified collaboration between animal and human health sectors. This synergy not only fosters shared learning but also drives investment in diagnostic innovation that benefits both fields. As a result, novel platforms have emerged that integrate multiplex assay functionality with digital connectivity, allowing real-time monitoring and seamless data exchange. In turn, these developments support epidemiological surveillance programs and targeted treatment protocols.

Moreover, regulatory frameworks are evolving in response to the accelerated pace of technological advancement. Harmonization efforts among global agencies aim to streamline approval processes for novel diagnostic reagents and platforms while ensuring robust validation standards. In parallel, supply chain resilience is becoming an imperative as stakeholders confront disruptions related to geopolitical tensions, trade policies, and logistic constraints. By anticipating these challenges and embracing adaptive strategies, practitioners and industry leaders can sustain innovation pipelines and deliver solutions that address the most pressing infectious disease threats in veterinary medicine.

Uncovering the Revolutionary Shifts Redefining the Veterinary Infectious Disease Diagnostics Landscape and Driving Clinical Innovation Across Animal Health Sectors

Across the veterinary diagnostics sector, several pivotal trends are converging to redefine the infection detection and monitoring paradigm. Foremost among these is the transition from single-analyte assays toward multiplex and syndromic panels. By enabling simultaneous detection of multiple pathogens, these advancements reduce time to diagnosis and provide a more comprehensive clinical picture. This transformative shift is further amplified by the miniaturization of analytic hardware, which supports deployment of portable devices in field settings and remote clinics.

Equally significant is the rise of molecular isothermal amplification techniques, which offer robust sensitivity comparable to polymerase chain reaction without the need for complex thermal cycling. Coupled with smartphone integration and cloud-based data management, point-of-care diagnostics are becoming increasingly user-friendly and accessible. As a result, diagnostic workflows are transitioning from centralized laboratories to decentralized frameworks, empowering veterinarians to make rapid, evidence-based decisions at the site of care.

In parallel, the incorporation of advanced data analytics and machine learning is unlocking novel insights from diagnostic outputs. Algorithms trained on extensive historical datasets can now predict outbreak patterns, guide antimicrobial stewardship, and optimize herd health management. Furthermore, collaborations between diagnostic developers and academic institutions are accelerating the translation of cutting-edge biomarkers into practical assays. Together, these shifts signal a new era in which diagnostic innovation and digital transformation converge to enhance animal welfare, protect public health, and drive economic value across the veterinary ecosystem.

Transitioning from traditional workflows, the procurement and supply chain models are adapting to support just-in-time delivery of critical reagents and consumables. Manufacturers are exploring localized distribution centers and additive manufacturing techniques to reduce lead times and mitigate logistics risks. Alongside these operational changes, regulatory agencies are updating guidelines to accommodate novel diagnostic modalities and digital health integrations. The combined effect of these shifts is a more responsive, resilient landscape that can adapt to emergent disease challenges with greater agility.

Evaluating the Comprehensive Effects of Newly Implemented United States Tariffs in 2025 on the Veterinary Infectious Disease Diagnostics Supply Chain and Innovation

The implementation of United States tariffs on veterinary diagnostic imports in 2025 has introduced a new layer of complexity to the global supply chain. Suppliers of reagents, test kits, and analyzer components are facing elevated costs that have begun to ripple through pricing structures. These added expenses place pressure on both manufacturers and end-use facilities to reevaluate procurement strategies and inventory management protocols.

In response to higher duty rates, several stakeholders are pursuing alternative sourcing avenues. Regional distribution networks are expanding their footprint to mitigate reliance on tariff-affected imports. At the same time, domestic producers are exploring strategic partnerships with component manufacturers to localize critical reagent production. This trend underscores the importance of a resilient supply ecosystem capable of withstanding regulatory and economic headwinds.

Moreover, increased input costs are incentivizing end users to optimize diagnostic workflows for cost efficiency. Veterinary hospitals and research laboratories are negotiating bundled service agreements and exploring reagent rental models to balance capital expenditure with operational flexibility. These adaptations reflect a broader shift toward collaborative purchasing and shared resource frameworks.

Looking ahead, industry participants anticipate that evolving trade policies will remain a defining factor in strategic decision-making. Companies that invest in agile manufacturing, robust supplier diversification, and proactive policy engagement will be best positioned to sustain growth. Ultimately, the capacity to navigate tariff dynamics will determine the long-term viability of new diagnostic platforms and their adoption across various veterinary settings.

Unveiling Comprehensive Segmentation Insights Revealing Critical Drivers and Growth Patterns Across Diverse Veterinary Infectious Disease Diagnostic Categories and Products

The veterinary infectious disease diagnostics market can be examined through several critical lenses that reveal unique drivers and emerging opportunities. When considering pathogen diversity, bacterial infections such as leptospirosis and brucellosis demand rapid confirmatory testing, while viral threats like parvovirus and canine distemper benefit from high-throughput molecular assays. Fungal pathogens, although less prevalent, necessitate specialized culture and serology platforms, and parasitic infestations require sensitive immunoassays to detect circulating antigens.

Turning to product offerings, consumables represent a significant share of laboratory expenditure, particularly the reagents and test kits that support both traditional and molecular workflows. Instruments and analyzers span a wide spectrum from clinical chemistry devices and hematology counters to point-of-care immunodiagnostic readers and advanced molecular diagnostic platforms. Each category carries distinct cost-benefit considerations related to throughput, ease of use, and maintenance requirements.

Within the framework of solution delivery, hardware investments in next-generation sequencers and multiplex analyzers are complemented by software solutions that enable data analytics and remote monitoring. Service agreements, including preventive maintenance and technical support, serve as a backbone for instrument uptime and operator proficiency, creating recurring revenue streams that underpin long-term vendor relationships.

Animal type segmentation further refines market focus. Companion animals such as cats and dogs benefit from rapid in-clinic assays that drive pet owner satisfaction, while livestock testing protocols for cattle, swine, and poultry emphasize herd-level health and productivity metrics. End users vary from in-house testing facilities at research institutions and shelters to dedicated veterinary hospitals and clinics. Each segment exhibits distinct adoption curves governed by budgetary constraints, throughput expectations, and regulatory compliance requirements.

Analyzing Geographical Patterns and Regional Dynamics Shaping the Future of Veterinary Infectious Disease Diagnostics across Established and Emerging Economies in Key Global Markets

Regional dynamics in veterinary infectious disease diagnostics are shaped by variations in animal ownership patterns, agricultural practices, and regulatory frameworks. In the Americas, the United States and Canada lead in technological adoption, leveraging strong research infrastructures and well-established veterinary networks. Markets in Latin America are emerging rapidly as livestock production expands and companion animal care becomes more sophisticated, driving demand for cost-effective diagnostic solutions.

Europe, Middle East & Africa present a diverse landscape. Western European countries benefit from harmonized regulations under the European Medicines Agency, facilitating cross-border distribution of advanced diagnostic kits and analyzers. In contrast, markets in the Middle East and Africa are characterized by fragmented regulatory environments and infrastructural constraints, which create opportunities for portable, robust testing platforms and capacity-building partnerships.

The Asia-Pacific region is distinguished by its high livestock density and growing companion animal segment in countries such as China, India, and Australia. Government initiatives promoting animal health and food safety have spurred investments in large-scale diagnostic laboratories. Meanwhile, smaller clinics are adopting point-of-care tests to meet increasing demand for rapid turnarounds, particularly in remote and rural geographies.

Across all regions, emerging economies are prioritizing investments in local production capabilities to reduce dependency on imports and improve cost resilience. Data sharing agreements and collaborative surveillance programs are on the rise, fostering a more integrated global ecosystem for disease monitoring and outbreak preparedness.

Profiling Leading Innovators and Strategic Partnerships Driving Breakthroughs in Veterinary Infectious Disease Diagnostics and Enhancing Market Competitiveness

Innovation in veterinary infectious disease diagnostics is propelled by a handful of leading companies that combine research excellence with strategic alliances. One category of market leaders has focused on developing comprehensive molecular diagnostic platforms that deliver multiplex pathogen detection with high analytical sensitivity. These platforms are complemented by reagent kits designed for field use, enabling seamless translation of laboratory capabilities into on-farm and in-clinic settings.

Another cohort of innovators has prioritized digital integration. By embedding connectivity features into analyzers and employing cloud-based data management, these firms offer real-time result sharing and remote monitoring services. Such capabilities support centralized oversight of multi-site operations, facilitating consistent quality standards and streamlined troubleshooting.

Strategic partnerships between diagnostic developers and academic or governmental research institutes have accelerated the validation of novel biomarkers and the launch of next-generation tests. Collaborative consortia that focus on zoonotic disease surveillance bring together cross-sector stakeholders to co-create solutions that address unmet needs. In parallel, service-oriented business models-featuring comprehensive maintenance agreements and user-training programs-have become critical differentiators that promote long-term customer loyalty.

Looking ahead, agile market entrants are expected to leverage modular platform designs, customizable workflows, and subscription-based software licensing to enhance flexibility and reduce total cost of ownership. These strategies reflect an industry-wide emphasis on delivering end-to-end solutions that align with the evolving demands of veterinary practitioners and research laboratories alike.

Implementing Targeted Strategies and Operational Frameworks for Industry Stakeholders to Accelerate Growth and Navigate Challenges in Veterinary Diagnostics

Industry leaders seeking to capitalize on emerging opportunities should prioritize investments in next-generation molecular platforms capable of multiplex pathogen detection. By expanding internal R&D capabilities or forging alliances with specialized biotechnology firms, they can accelerate time to market and ensure alignment with clinical needs. In addition, strengthening supply chain resilience through diversified sourcing strategies and localized manufacturing will mitigate tariff and logistics risks.

Digital transformation should be advanced through the integration of software solutions that enable remote monitoring, data analytics, and predictive modeling. Piloting these technologies in select sites will provide valuable user feedback and inform scalable deployment plans. Concurrently, engagement with regulatory authorities and participation in harmonization initiatives will streamline approval pathways for novel diagnostics and foster a more predictable innovation landscape.

Cross-sector collaboration represents another critical success factor. By partnering with academic laboratories, public health agencies, and agricultural stakeholders, organizations can access unique datasets and validate emerging biomarkers under real-world conditions. Establishing formal consortia for zoonotic disease surveillance also enhances market credibility and opens new channels for funding and co-development.

Finally, workforce development must be addressed through targeted training programs that elevate operator proficiency and technical expertise. Investing in customer education-via workshops, online modules, and certification tracks-reinforces product value propositions and drives sustained market engagement.

Outlining Rigorous Research Methodology Combining Quantitative Analysis and Expert Validation to Ensure Robust Insights into Veterinary Infectious Disease Diagnostics

This report's findings are grounded in a rigorous research methodology that integrates both quantitative analysis and expert validation. Secondary research formed the foundation of market understanding, drawing on peer-reviewed journals, public health databases, regulatory filings, and technical white papers. This comprehensive literature review ensured that emerging trends and technological breakthroughs were thoroughly captured.

Primary research was conducted through in-depth interviews with key opinion leaders, including veterinary practitioners, laboratory directors, academic researchers, and industry executives. These conversations provided real-world perspectives on diagnostic adoption drivers, workflow inefficiencies, and unmet clinical needs. In addition, targeted surveys of end users were deployed to quantify adoption levels, budgetary constraints, and purchasing preferences across different segments.

Data triangulation techniques were applied to reconcile findings from multiple sources and enhance overall accuracy. Preliminary conclusions were subjected to a validation round with an advisory panel composed of subject matter experts, who provided critical feedback on assumptions and scenario analyses. This iterative review cycle helped refine market segmentation frameworks and ensure robustness of regional and regulatory insights.

Quality control measures, including cross-dataset consistency checks and hypothesis testing, were implemented throughout the research process. The result is a set of actionable insights and strategic recommendations that reflect both empirical data and frontline expertise, empowering decision-makers to navigate the dynamic landscape of veterinary infectious disease diagnostics with confidence.

Summarizing Key Insights and Strategic Imperatives to Inform Decision Making in the Evolving Veterinary Diagnostics Ecosystem for Infectious Diseases

In summary, the veterinary infectious disease diagnostics market is undergoing a period of profound transformation driven by technological innovation, regulatory evolution, and shifting trade policies. The rise of multiplex molecular assays, point-of-care devices, and data analytics platforms is redefining diagnostic workflows and enabling more proactive disease management across both companion and production animals.

Tariff adjustments in 2025 have underscored the necessity of supply chain resilience and strategic procurement models. Organizations that invest in localized manufacturing, supplier diversification, and collaborative purchasing arrangements will be best prepared to navigate cost pressures and maintain service continuity. Meanwhile, segmentation analysis highlights distinct adoption patterns across disease categories, product typologies, and end-use settings, guiding targeted go-to-market strategies.

Regional dynamics further illustrate the importance of aligning product portfolios with local infrastructure, regulatory requirements, and customer needs. From the technologically advanced markets of North America and Western Europe to the fast-growing economies of Asia-Pacific and Latin America, opportunities abound for agile companies that tailor solutions effectively.

Ultimately, success in this evolving ecosystem will hinge on integrated strategies that combine innovation in hardware, software, and services with strong stakeholder partnerships and robust market intelligence. Decision-makers who leverage these insights and proactively implement recommended actions will secure a leadership position in the next chapter of veterinary diagnostics.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Market Sizing & Forecasting

5. Market Dynamics

  • 5.1. Development of multiplex PCR panels for simultaneous detection of zoonotic agents in companion animals
  • 5.2. Expansion of CRISPR-based diagnostics for rapid and field-deployable veterinary pathogen identification
  • 5.3. Integration of AI-driven image analysis tools to detect early infectious disease markers in livestock health screening
  • 5.4. Growth of portable microfluidic biosensor devices for on-site screening of antimicrobial resistance in farm animals
  • 5.5. Adoption of next-generation sequencing for comprehensive surveillance of emerging viral and bacterial pathogens
  • 5.6. Implementation of telemedicine platforms with remote diagnostic testing for improved veterinary care accessibility in rural areas
  • 5.7. Standardization and regulatory harmonization of veterinary diagnostic assays to streamline global market approvals
  • 5.8. Advancement of lateral flow immunoassays for cost-effective routine monitoring of endemic diseases in poultry operations
  • 5.9. Utilization of digital data analytics platforms to integrate diagnostic results with farm management systems for real-time insights
  • 5.10. Expansion of companion animal infectious disease diagnostics driven by increasing pet healthcare expenditure and wellness trends

6. Market Insights

  • 6.1. Porter's Five Forces Analysis
  • 6.2. PESTLE Analysis

7. Cumulative Impact of United States Tariffs 2025

8. Veterinary Infectious Disease Diagnostics Market, by Disease Category

  • 8.1. Introduction
  • 8.2. Bacterial
  • 8.3. Fungal
  • 8.4. Parasitic
  • 8.5. Viral

9. Veterinary Infectious Disease Diagnostics Market, by Product

  • 9.1. Introduction
  • 9.2. Consumables
    • 9.2.1. Reagents
    • 9.2.2. Test kits
  • 9.3. Instruments/Analyzers
    • 9.3.1. Clinical chemistry analyzers
    • 9.3.2. Hematology analyzers
    • 9.3.3. Immunodiagnostic analyzers
    • 9.3.4. Molecular diagnostic analyzers

10. Veterinary Infectious Disease Diagnostics Market, by Offering

  • 10.1. Introduction
  • 10.2. Hardware
  • 10.3. Services
  • 10.4. Software

11. Veterinary Infectious Disease Diagnostics Market, by Animal Type

  • 11.1. Introduction
  • 11.2. Companion Animals
    • 11.2.1. Cat
    • 11.2.2. Dog
  • 11.3. Livestock/Production Animals
    • 11.3.1. Cattle
    • 11.3.2. Goats
    • 11.3.3. Poultry
    • 11.3.4. Sheep
    • 11.3.5. Swine

12. Veterinary Infectious Disease Diagnostics Market, by End Use

  • 12.1. Introduction
  • 12.2. In-House Testing Facilities
    • 12.2.1. Animal Shelters
    • 12.2.2. Pet Owners
  • 12.3. Research Laboratories
  • 12.4. Veterinary Hospitals & Clinics

13. Americas Veterinary Infectious Disease Diagnostics Market

  • 13.1. Introduction
  • 13.2. United States
  • 13.3. Canada
  • 13.4. Mexico
  • 13.5. Brazil
  • 13.6. Argentina

14. Europe, Middle East & Africa Veterinary Infectious Disease Diagnostics Market

  • 14.1. Introduction
  • 14.2. United Kingdom
  • 14.3. Germany
  • 14.4. France
  • 14.5. Russia
  • 14.6. Italy
  • 14.7. Spain
  • 14.8. United Arab Emirates
  • 14.9. Saudi Arabia
  • 14.10. South Africa
  • 14.11. Denmark
  • 14.12. Netherlands
  • 14.13. Qatar
  • 14.14. Finland
  • 14.15. Sweden
  • 14.16. Nigeria
  • 14.17. Egypt
  • 14.18. Turkey
  • 14.19. Israel
  • 14.20. Norway
  • 14.21. Poland
  • 14.22. Switzerland

15. Asia-Pacific Veterinary Infectious Disease Diagnostics Market

  • 15.1. Introduction
  • 15.2. China
  • 15.3. India
  • 15.4. Japan
  • 15.5. Australia
  • 15.6. South Korea
  • 15.7. Indonesia
  • 15.8. Thailand
  • 15.9. Philippines
  • 15.10. Malaysia
  • 15.11. Singapore
  • 15.12. Vietnam
  • 15.13. Taiwan

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. IDEXX Laboratories, Inc.
    • 16.3.2. Zoetis Inc.
    • 16.3.3. Agrolabo S.p.A.
    • 16.3.4. Antech Diagnostics, Inc.
    • 16.3.5. Bio-Rad Laboratories, Inc.
    • 16.3.6. Biogal Galed Labs
    • 16.3.7. BioMerieux S.A.
    • 16.3.8. BioNote, Inc.
    • 16.3.9. Demeditec Diagnostics GmbH
    • 16.3.10. DEXX Laboratories Inc.
    • 16.3.11. Eurofins Technologies
    • 16.3.12. Fassisi GmbH
    • 16.3.13. FUJIFILM Holdings Corporation
    • 16.3.14. IDvet
    • 16.3.15. Mars, Incorporated
    • 16.3.16. Merck & Co., Inc.
    • 16.3.17. Neogen Corporation
    • 16.3.18. Nisseiken Co., Ltd
    • 16.3.19. Qiagen N.V.
    • 16.3.20. Randox Laboratories, Ltd.
    • 16.3.21. Shenzhen Bioeasy Biotechnology Co., Ltd.
    • 16.3.22. Shenzhen Mindray Animal Medical Technology Co., Ltd.
    • 16.3.23. SKYER, Inc.
    • 16.3.24. Skyla Corporation
    • 16.3.25. Thermo Fisher Scientific Inc.
    • 16.3.26. Vimian Group AB
    • 16.3.27. Virbac S.A.

17. ResearchAI

18. ResearchStatistics

19. ResearchContacts

20. ResearchArticles

21. Appendix

LIST OF FIGURES

  • FIGURE 1. VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET RESEARCH PROCESS
  • FIGURE 2. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 3. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 4. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE CATEGORY, 2024 VS 2030 (%)
  • FIGURE 6. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE CATEGORY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2024 VS 2030 (%)
  • FIGURE 8. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY OFFERING, 2024 VS 2030 (%)
  • FIGURE 10. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY OFFERING, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2030 (%)
  • FIGURE 12. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USE, 2024 VS 2030 (%)
  • FIGURE 14. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 16. AMERICAS VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 18. UNITED STATES VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 21. ASIA-PACIFIC VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 22. ASIA-PACIFIC VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 23. VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 24. VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2024
  • FIGURE 25. VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: RESEARCHAI
  • FIGURE 26. VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: RESEARCHSTATISTICS
  • FIGURE 27. VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: RESEARCHCONTACTS
  • FIGURE 28. VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: RESEARCHARTICLES

LIST OF TABLES

  • TABLE 1. VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, 2025-2030 (USD MILLION)
  • TABLE 5. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 7. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 9. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE CATEGORY, 2025-2030 (USD MILLION)
  • TABLE 11. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY BACTERIAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY BACTERIAL, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 13. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY FUNGAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY FUNGAL, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 15. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PARASITIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PARASITIC, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 17. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY VIRAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY VIRAL, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 19. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 21. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 23. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY REAGENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY REAGENTS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 25. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY TEST KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY TEST KITS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 27. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
  • TABLE 29. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 31. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY ANALYZERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY ANALYZERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 33. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY ANALYZERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY ANALYZERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 35. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY IMMUNODIAGNOSTIC ANALYZERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY IMMUNODIAGNOSTIC ANALYZERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 37. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC ANALYZERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC ANALYZERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 39. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, 2025-2030 (USD MILLION)
  • TABLE 41. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY OFFERING, 2025-2030 (USD MILLION)
  • TABLE 43. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY HARDWARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY HARDWARE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 45. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY SERVICES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 47. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY SOFTWARE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 49. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
  • TABLE 51. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 53. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY CAT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY CAT, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 55. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DOG, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DOG, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 57. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2025-2030 (USD MILLION)
  • TABLE 59. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK/PRODUCTION ANIMALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK/PRODUCTION ANIMALS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 61. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY CATTLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY CATTLE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 63. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY GOATS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY GOATS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 65. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY POULTRY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY POULTRY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 67. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY SHEEP, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY SHEEP, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 69. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY SWINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY SWINE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 71. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK/PRODUCTION ANIMALS, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK/PRODUCTION ANIMALS, 2025-2030 (USD MILLION)
  • TABLE 73. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
  • TABLE 75. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 77. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL SHELTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL SHELTERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 79. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PET OWNERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PET OWNERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 81. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, 2025-2030 (USD MILLION)
  • TABLE 83. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 85. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY VETERINARY HOSPITALS & CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY VETERINARY HOSPITALS & CLINICS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 87. AMERICAS VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 88. AMERICAS VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE CATEGORY, 2025-2030 (USD MILLION)
  • TABLE 89. AMERICAS VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 90. AMERICAS VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 91. AMERICAS VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 92. AMERICAS VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
  • TABLE 93. AMERICAS VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, 2018-2024 (USD MILLION)
  • TABLE 94. AMERICAS VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, 2025-2030 (USD MILLION)
  • TABLE 95. AMERICAS VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
  • TABLE 96. AMERICAS VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY OFFERING, 2025-2030 (USD MILLION)
  • TABLE 97. AMERICAS VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 98. AMERICAS VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
  • TABLE 99. AMERICAS VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2024 (USD MILLION)
  • TABLE 100. AMERICAS VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2025-2030 (USD MILLION)
  • TABLE 101. AMERICAS VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK/PRODUCTION ANIMALS, 2018-2024 (USD MILLION)
  • TABLE 102. AMERICAS VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK/PRODUCTION ANIMALS, 2025-2030 (USD MILLION)
  • TABLE 103. AMERICAS VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 104. AMERICAS VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
  • TABLE 105. AMERICAS VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, 2018-2024 (USD MILLION)
  • TABLE 106. AMERICAS VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, 2025-2030 (USD MILLION)
  • TABLE 107. AMERICAS VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 108. AMERICAS VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 109. UNITED STATES VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 110. UNITED STATES VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE CATEGORY, 2025-2030 (USD MILLION)
  • TABLE 111. UNITED STATES VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 112. UNITED STATES VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 113. UNITED STATES VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 114. UNITED STATES VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
  • TABLE 115. UNITED STATES VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, 2018-2024 (USD MILLION)
  • TABLE 116. UNITED STATES VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, 2025-2030 (USD MILLION)
  • TABLE 117. UNITED STATES VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
  • TABLE 118. UNITED STATES VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY OFFERING, 2025-2030 (USD MILLION)
  • TABLE 119. UNITED STATES VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 120. UNITED STATES VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
  • TABLE 121. UNITED STATES VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2024 (USD MILLION)
  • TABLE 122. UNITED STATES VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2025-2030 (USD MILLION)
  • TABLE 123. UNITED STATES VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK/PRODUCTION ANIMALS, 2018-2024 (USD MILLION)
  • TABLE 124. UNITED STATES VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK/PRODUCTION ANIMALS, 2025-2030 (USD MILLION)
  • TABLE 125. UNITED STATES VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 126. UNITED STATES VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
  • TABLE 127. UNITED STATES VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, 2018-2024 (USD MILLION)
  • TABLE 128. UNITED STATES VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, 2025-2030 (USD MILLION)
  • TABLE 129. UNITED STATES VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
  • TABLE 130. UNITED STATES VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
  • TABLE 131. CANADA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 132. CANADA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE CATEGORY, 2025-2030 (USD MILLION)
  • TABLE 133. CANADA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 134. CANADA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 135. CANADA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 136. CANADA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
  • TABLE 137. CANADA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, 2018-2024 (USD MILLION)
  • TABLE 138. CANADA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, 2025-2030 (USD MILLION)
  • TABLE 139. CANADA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
  • TABLE 140. CANADA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY OFFERING, 2025-2030 (USD MILLION)
  • TABLE 141. CANADA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 142. CANADA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
  • TABLE 143. CANADA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2024 (USD MILLION)
  • TABLE 144. CANADA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2025-2030 (USD MILLION)
  • TABLE 145. CANADA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK/PRODUCTION ANIMALS, 2018-2024 (USD MILLION)
  • TABLE 146. CANADA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK/PRODUCTION ANIMALS, 2025-2030 (USD MILLION)
  • TABLE 147. CANADA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 148. CANADA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
  • TABLE 149. CANADA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, 2018-2024 (USD MILLION)
  • TABLE 150. CANADA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, 2025-2030 (USD MILLION)
  • TABLE 151. MEXICO VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 152. MEXICO VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE CATEGORY, 2025-2030 (USD MILLION)
  • TABLE 153. MEXICO VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 154. MEXICO VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 155. MEXICO VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 156. MEXICO VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
  • TABLE 157. MEXICO VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, 2018-2024 (USD MILLION)
  • TABLE 158. MEXICO VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, 2025-2030 (USD MILLION)
  • TABLE 159. MEXICO VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
  • TABLE 160. MEXICO VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY OFFERING, 2025-2030 (USD MILLION)
  • TABLE 161. MEXICO VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 162. MEXICO VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
  • TABLE 163. MEXICO VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2024 (USD MILLION)
  • TABLE 164. MEXICO VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2025-2030 (USD MILLION)
  • TABLE 165. MEXICO VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK/PRODUCTION ANIMALS, 2018-2024 (USD MILLION)
  • TABLE 166. MEXICO VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK/PRODUCTION ANIMALS, 2025-2030 (USD MILLION)
  • TABLE 167. MEXICO VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 168. MEXICO VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
  • TABLE 169. MEXICO VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, 2018-2024 (USD MILLION)
  • TABLE 170. MEXICO VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, 2025-2030 (USD MILLION)
  • TABLE 171. BRAZIL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 172. BRAZIL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE CATEGORY, 2025-2030 (USD MILLION)
  • TABLE 173. BRAZIL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 174. BRAZIL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 175. BRAZIL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 176. BRAZIL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
  • TABLE 177. BRAZIL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, 2018-2024 (USD MILLION)
  • TABLE 178. BRAZIL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, 2025-2030 (USD MILLION)
  • TABLE 179. BRAZIL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
  • TABLE 180. BRAZIL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY OFFERING, 2025-2030 (USD MILLION)
  • TABLE 181. BRAZIL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 182. BRAZIL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
  • TABLE 183. BRAZIL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2024 (USD MILLION)
  • TABLE 184. BRAZIL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2025-2030 (USD MILLION)
  • TABLE 185. BRAZIL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK/PRODUCTION ANIMALS, 2018-2024 (USD MILLION)
  • TABLE 186. BRAZIL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK/PRODUCTION ANIMALS, 2025-2030 (USD MILLION)
  • TABLE 187. BRAZIL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 188. BRAZIL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
  • TABLE 189. BRAZIL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, 2018-2024 (USD MILLION)
  • TABLE 190. BRAZIL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, 2025-2030 (USD MILLION)
  • TABLE 191. ARGENTINA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 192. ARGENTINA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE CATEGORY, 2025-2030 (USD MILLION)
  • TABLE 193. ARGENTINA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 194. ARGENTINA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 195. ARGENTINA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 196. ARGENTINA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
  • TABLE 197. ARGENTINA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, 2018-2024 (USD MILLION)
  • TABLE 198. ARGENTINA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, 2025-2030 (USD MILLION)
  • TABLE 199. ARGENTINA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
  • TABLE 200. ARGENTINA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY OFFERING, 2025-2030 (USD MILLION)
  • TABLE 201. ARGENTINA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 202. ARGENTINA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
  • TABLE 203. ARGENTINA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2024 (USD MILLION)
  • TABLE 204. ARGENTINA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2025-2030 (USD MILLION)
  • TABLE 205. ARGENTINA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK/PRODUCTION ANIMALS, 2018-2024 (USD MILLION)
  • TABLE 206. ARGENTINA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK/PRODUCTION ANIMALS, 2025-2030 (USD MILLION)
  • TABLE 207. ARGENTINA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 208. ARGENTINA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
  • TABLE 209. ARGENTINA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, 2018-2024 (USD MILLION)
  • TABLE 210. ARGENTINA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, 2025-2030 (USD MILLION)
  • TABLE 211. EUROPE, MIDDLE EAST & AFRICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 212. EUROPE, MIDDLE EAST & AFRICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE CATEGORY, 2025-2030 (USD MILLION)
  • TABLE 213. EUROPE, MIDDLE EAST & AFRICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 214. EUROPE, MIDDLE EAST & AFRICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 215. EUROPE, MIDDLE EAST & AFRICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 216. EUROPE, MIDDLE EAST & AFRICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
  • TABLE 217. EUROPE, MIDDLE EAST & AFRICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, 2018-2024 (USD MILLION)
  • TABLE 218. EUROPE, MIDDLE EAST & AFRICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, 2025-2030 (USD MILLION)
  • TABLE 219. EUROPE, MIDDLE EAST & AFRICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
  • TABLE 220. EUROPE, MIDDLE EAST & AFRICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY OFFERING, 2025-2030 (USD MILLION)
  • TABLE 221. EUROPE, MIDDLE EAST & AFRICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 222. EUROPE, MIDDLE EAST & AFRICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
  • TABLE 223. EUROPE, MIDDLE EAST & AFRICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2024 (USD MILLION)
  • TABLE 224. EUROPE, MIDDLE EAST & AFRICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2025-2030 (USD MILLION)
  • TABLE 225. EUROPE, MIDDLE EAST & AFRICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK/PRODUCTION ANIMALS, 2018-2024 (USD MILLION)
  • TABLE 226. EUROPE, MIDDLE EAST & AFRICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK/PRODUCTION ANIMALS, 2025-2030 (USD MILLION)
  • TABLE 227. EUROPE, MIDDLE EAST & AFRICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 228. EUROPE, MIDDLE EAST & AFRICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
  • TABLE 229. EUROPE, MIDDLE EAST & AFRICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, 2018-2024 (USD MILLION)
  • TABLE 230. EUROPE, MIDDLE EAST & AFRICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, 2025-2030 (USD MILLION)
  • TABLE 231. EUROPE, MIDDLE EAST & AFRICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 232. EUROPE, MIDDLE EAST & AFRICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 234. UNITED KINGDOM VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE CATEGORY, 2025-2030 (USD MILLION)
  • TABLE 235. UNITED KINGDOM VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 236. UNITED KINGDOM VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 237. UNITED KINGDOM VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 238. UNITED KINGDOM VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
  • TABLE 239. UNITED KINGDOM VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, 2018-2024 (USD MILLION)
  • TABLE 240. UNITED KINGDOM VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, 2025-2030 (USD MILLION)
  • TABLE 241. UNITED KINGDOM VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
  • TABLE 242. UNITED KINGDOM VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY OFFERING, 2025-2030 (USD MILLION)
  • TABLE 243. UNITED KINGDOM VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 244. UNITED KINGDOM VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
  • TABLE 245. UNITED KINGDOM VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2024 (USD MILLION)
  • TABLE 246. UNITED KINGDOM VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2025-2030 (USD MILLION)
  • TABLE 247. UNITED KINGDOM VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK/PRODUCTION ANIMALS, 2018-2024 (USD MILLION)
  • TABLE 248. UNITED KINGDOM VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK/PRODUCTION ANIMALS, 2025-2030 (USD MILLION)
  • TABLE 249. UNITED KINGDOM VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 250. UNITED KINGDOM VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
  • TABLE 251. UNITED KINGDOM VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, 2018-2024 (USD MILLION)
  • TABLE 252. UNITED KINGDOM VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, 2025-2030 (USD MILLION)
  • TABLE 253. GERMANY VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 254. GERMANY VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE CATEGORY, 2025-2030 (USD MILLION)
  • TABLE 255. GERMANY VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 256. GERMANY VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 257. GERMANY VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 258. GERMANY VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
  • TABLE 259. GERMANY VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, 2018-2024 (USD MILLION)
  • TABLE 260. GERMANY VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, 2025-2030 (USD MILLION)
  • TABLE 261. GERMANY VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
  • TABLE 262. GERMANY VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY OFFERING, 2025-2030 (USD MILLION)
  • TABLE 263. GERMANY VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 264. GERMANY VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
  • TABLE 265. GERMANY VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2024 (USD MILLION)
  • TABLE 266. GERMANY VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2025-2030 (USD MILLION)
  • TABLE 267. GERMANY VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK/PRODUCTION ANIMALS, 2018-2024 (USD MILLION)
  • TABLE 268. GERMANY VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK/PRODUCTION ANIMALS, 2025-2030 (USD MILLION)
  • TABLE 269. GERMANY VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 270. GERMANY VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)

TA